FDA Inspection
Zhejiang Huahai Pharmaceutical Co., Ltd.Zhejiang Huahai Pharmaceutical Co., Ltd. – FDA Inspection, May 31, 2019
Record Details
This FDA Inspection record concerns Zhejiang Huahai Pharmaceutical Co., Ltd., with an inspection on May 31, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 2b5b7233-044f-42f2-ac3f-00e6696bfc49
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1093250
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Huahai Pharmaceutical Co., Ltd.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| April 24, 2026 | Not classified | Office of Inspections and Investigations | |
| January 24, 2025 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 2, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 28, 2019 | Not classified | Office of Inspections and Investigations | |
| January 26, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Zhejiang Huahai Pharmaceutical Co., Ltd.
- FDA Inspection 1319736 - 2026-04-24
- FDA Inspection 1259818 - 2025-01-24
- FDA Inspection 1149252 - 2021-07-02
- FDA Inspection 1094941 - 2019-06-28
- FDA Inspection 1042575 - 2018-01-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.